The final installment of Scrip’s round-up of industry insiders’ views of the big issues that will shape 2020 focuses on one figure that was a recurring theme among the 80+ people we spoke to: the patient.
Although patients have obviously loomed large throughout the history of the biopharma industry, recent years have seen a gathering interest in re-appraising their needs, wants and
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?